Andrea Angela Becerril-Osnaya

Andrea Angela Becerril-Osnaya


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KRKaren Roa-Tort
Karen Roa-Tort
YSYael Saavedra
Yael Saavedra
AVAngélica Villanueva-Martínez
Angélica Villanueva-Martínez
GAGanem Adriana
Ganem Adriana
LCLaura Abril Pérez Carranza
Laura Abril Pérez Carranza
JRJosué D. Rivera-Fernández
Josué D. Rivera-Fernández
Photodynamic therapy (PDT) has been based on using photosensitizers (PS) and applying light of a specific wavelength. When this technique is used for treating infections, it is known as antimicrobial photodynamic therapy (aPDT). Currently, the use of lighting sources for in vitro studies using aPDT is generally applied in multiwell cell culture plates; however, depending on the lighting arrangement, there are usually errors in the application of the technique because the light from a well can affect the neighboring wells or it may be that not all the wells are used in the same experiment. In addition, one must be awarded high irradiance values, which can cause unwanted photothermal problems in the studies. Thus, this manuscript presents an in vitro antimicrobial photodynamic therapy for a Pseudomonas aeruginosa (P. aeruginosa) and methicillin-resistant Staphylococcus aureus (MRSA) inhibition study using an arrangement of thermally isolated and independently illuminated green light source systems for eight tubes in vitro aPDT, determining the effect of the following factors: (i) irradiance level, (ii) exposure time, and (iii) Rose Bengal (RB) concentration (used as a PS), registering the Pseudomonas aeruginosa (P. aeruginosa) and methicillin-resistant Staphylococcus aureus (MRSA) inhibition rates. The results show that in the dark, RB had a poor antimicrobial rate for P. aeruginosa, finding the maximum inhibition (2.7%) at 30 min with an RB concentration of 3 µg/mL. However, by applying light in a correct dosage (time × irradiance) and the adequate RB concentration, the inhibition rate increased by over 37%. In the case of MRSA, there was no significant inhibition with RB in complete darkness and, in contrast, the rate was 100% for those experiments that were irradiated.

29 January 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
CRCarolina Romo-González
Carolina Romo-González
AAAlejandra Aquino-Andrade
Alejandra Aquino-Andrade
LCLaura Abril Pérez Carranza
Laura Abril Pérez Carranza
DCDiana Chaparro-Camacho
Diana Chaparro-Camacho
ABAndrea Angela Becerril-Osnaya
Andrea Angela Becerril-Osnaya
MGMaria Teresa García-Romero
Maria Teresa García-Romero
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction and susceptibility to Staphylococcus aureus colonization. Biofilm formation modifies antibiotic resistance and the host immune response. This longitudinal study analyzed antimicrobial susceptibility and biofilm formation in 136 S. aureus isolates obtained over 18 months from lesional, nonlesional, and nasal samples of 26 pediatric patients with moderate-to-severe AD. Antimicrobial susceptibility testing was determined by the disk diffusion method, and biofilm production was quantified using a crystal violet microtiter assay. Clinical parameters, including disease severity, treatment response, and the administration of dilute bleach baths, were evaluated in relation to bacterial characteristics. Overall, 60.2% of isolates exhibited moderate-to-strong biofilm production, significantly associated with severe AD at baseline (p = 0.01), lack of clinical improvement (p = 0.04), and persistent moderate-to-severe disease (p = 0.01). Resistance rates for penicillin, gentamicin, clindamycin, and erythromycin exceeded 15%. Isolates from patients using dilute bleach baths showed greater resistance to ciprofloxacin (p < 0.0001) and exhibited constitutive or inducible macrolide–lincosamide–streptogramin B (MLSB) resistance, with ermA detected in 80% of inducible cases. In conclusion, S. aureus biofilm formation is linked to disease severity and treatment failure in pediatric AD, underscoring the importance of culture-guided, targeted therapeutic strategies.

30 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
CRCarolina Romo-González
Carolina Romo-González
AAAlejandra Aquino-Andrade
Alejandra Aquino-Andrade
LCLaura Abril Pérez Carranza
Laura Abril Pérez Carranza
CDChaparro-Camacho Diana
Chaparro-Camacho Diana
ABAndrea Angela Becerril-Osnaya
Andrea Angela Becerril-Osnaya
MGMaria Teresa García-Romero
Maria Teresa García-Romero
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction and susceptibility to Staphylococcus aureus colonization. Biofilm formation alters antibiotic resistance and the immune response. This study examines the antimicrobial susceptibility patterns and biofilm formation of S. aureus isolates from pediatric AD patients. Methods: A prospective longitudinal observational study was conducted with 136 S. aureus isolates collected from 26 pediatric patients with moderate-to-severe AD over 18 months. Isolates were obtained from both lesional and nonlesional skin and from nares. Antimicrobial susceptibility was evaluated using the disk diffusion method, whereas biofilm production was quantified using a crystal violet microtiter assay. Clinical characteristics, including AD severity, response to treatment, and the use of adjunctive dilute bleach baths, were analyzed for associations with S. aureus features. Results: Of the isolates, 60.2% exhibited moderate-to-strong biofilm production, which was associated with severe AD at baseline (p=0.01), lack of clinical improvement (p=0.04), and persistent moderate-severe disease (p=0.01). The antimicrobial resistance rates for penicillin, gentamicin, clindamycin, and erythromycin exceeded 15%. Isolates from patients receiving dilute bleach baths presented greater resistance to ciprofloxacin (p<0.0001) and constitutive and inducible macrolide-lincosamide-streptogramin B resistance (MLSB). Inducible MLSB was associated with the ermA gene in 80% of the cases. Conclusions: S. aureus biofilm formation correlates with disease severity and treatment resistance in pediatric AD patients. These findings highlight the need for culture-guided therapy and emphasize the importance of tailored strategies to manage S. aureus colonization and infection in AD patients. Importance: In this longitudinal study of 136 S. aureus isolates from 26 pediatric patients with atopic dermatitis, we examined the antimicrobial susceptibility patterns and biofilm formation of S. aureus . We found 60.2% exhibited moderate-to-strong biofilm production, which was significantly associated with severe atopic dermatitis at baseline, lack of clinical improvement, and persistent moderate-severe disease. The antimicrobial resistance rates for penicillin, gentamicin, clindamycin, and erythromycin were suboptimal exceeding 15%. Isolates from patients receiving dilute bleach baths presented greater resistance to ciprofloxacin and constitutive and inducible MLSB resistance. Inducible MLSB resistance was associated with the ermA gene in 80% of the cases. These findings emphasize the importance of culture-guided therapy in skin and soft tissue infections associated to atopic dermatitis, the need for tailored strategies to manage S. aureus colonization and infection in AD patients, and of developing alternative treatments targeting biofilm and quorum-sensing mechanisms.